You are currently viewing Synertec reaches a major milestone on the CSIRO’s National Vaccine and Therapeutics Lab

Synertec reaches a major milestone on the CSIRO’s National Vaccine and Therapeutics Lab

  • Post category:News
  • Reading time:1 mins read

Synertec’s Advanced Manufacturing Team have reached a major milestone on the CSIRO’s National Vaccine and Therapeutics Lab project which was recently granted certification by the Office of the Gene Technology Regulator (OGTR) at the Department of Health. Synertec executed the schematic & detailed design, provided contract documentation and tendering services, contract administration and technical support as well as commissioning, qualification and most recently construction management services.

This facility is a first in Australia for single use technology for multi-product biologicals for both API and Final Product Manufacture including sterile filling. Synertec worked closely with the CSIRO team to define the user requirements, engage with the Therapeutic Goods Administration of Australia and overcome the many challenges of construction during Covid.